December 16, 2016
DEA Reduces Opioid Production
The supply of almost every Schedule II opioid manufactured in the U.S. will be reduced 25% or more in 2017, as required by the Drug Enforcement Administration (DEA). DEA expects the new quota will be sufficient to meet the estimated medical scientific research, industrial and